Patent details
EP2286663
Title:
Methods and compositions for treating ectoparasite infestation
The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
Ok
Cancel
You have not selected any documents
Ok
Basic Information
Publication number:
EP2286663
WO Application Number:
Type:
European Patent Granted for NL
Status:
Expired. Art. 36.6 ROW
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP10183992.6
WO Publication Number:
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
United States of America (US)
Publications:
Dates
Filing date:
14/04/2003
Grant date:
01/03/2017
EP Publication Date:
23/02/2011
WO Publication Date:
Claims Translations Received Date:
Claims Translation B1 Received Date:
16/05/2017
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
01/03/2017
EP B1 Publication Date:
01/03/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
13/04/2023
Lapsed By Expiration Date:
14/04/2023
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
22/09/2020
Name:
Nuvo Pharmaceuticals (Ireland) Designated Activity Company
Address:
88 Harcourt Street, D02DK18, Dublin 2, Ireland (IE)
Historical Applicant/holder
From:
01/02/2019
To:
01/02/2019
Name:
Nuvo Pharmaceuticals Inc.
Address:
6733 Mississauga Road, Unit 610, L5N 6J5, Mississauga, ON, Canada (CA)
From:
01/02/2019
To:
22/09/2020
Name:
Nuvo Pharmaceuticals (Ireland) Limited
Address:
c/o Mespil Business Centre
Sussex Road, Dublin 4, Ireland (IE)
From:
01/03/2017
To:
01/02/2019
Name:
Piedmont Pharmaceuticals, LLC
Address:
204 Muirs Chapel road, Suite 200, GREENSBORO, NC 27410, United States of America (US)
Domicile Holder
Name:
ir. A.R. Aalbers
From:
16/05/2017
Address:
De Vries & Metman
Overschiestraat 180, 1062 XK, Amsterdam, Netherlands (NL)
To:
Inventor
1
Name:
Palma, Kathleen, G.
Address:
McLeansville, NC 27301, United States of America (US)
2
Name:
Campbell, William, R.
Address:
Jamestown, NC 27282, United States of America (US)
3
Name:
Paulsen, Neil, E.
Address:
Davidson, NC 28036, United States of America (US)
Priority
Priority Patent Number:
136075
Priority Date:
29/04/2002
Priority Country:
United States of America (US)
Classification
IPC or IDT classification:
A01N 25/00 ;
A01N 25/10 ;
A01N 43/90 ;
A01N 49/00 ;
A01N 55/10 ;
Publication
Bulletin
1
Bulletin Heading:
VRV
Journal edition number:
16/23
Publication date:
19/04/2023
Description:
Lapse or annulment
2
Bulletin Heading:
CO
Journal edition number:
42/20
Publication date:
14/10/2020
Description:
Changes in the Netherlands Patent Register
3
Bulletin Heading:
CO
Journal edition number:
15/19
Publication date:
10/04/2019
Description:
Changes in the Netherlands Patent Register
4
Bulletin Heading:
CO
Journal edition number:
15/19
Publication date:
10/04/2019
Description:
Changes in the Netherlands Patent Register
5
Bulletin Heading:
EP3
Journal edition number:
21/17
Publication date:
24/05/2017
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
6
Bulletin Heading:
EP2
Journal edition number:
09/17
Publication date:
01/03/2017
Description:
European patents granted for the Netherlands
European Patent Bulletin
Issue number:
201709
Publication date:
01/03/2017
Description:
Grant (B1)
Deed
Change of owner(s)
Change Kind/ Decision Type:
Change of Legal Entity
Deed Number:
RC202001848A
Date Registered:
22/09/2020
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Nuvo Pharmaceuticals (Ireland) Designated Activity Company
Address:
88 Harcourt Street, D02DK18, Dublin 2, Ireland (IE)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201900188A
Date Registered:
01/02/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Nuvo Pharmaceuticals Inc.
Address:
6733 Mississauga Road, Unit 610, L5N 6J5, Mississauga, ON, Canada (CA)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC201900188B
Date Registered:
01/02/2019
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
ir. M.F.J.M. Ketelaars c.s.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Nuvo Pharmaceuticals (Ireland) Limited
Address:
c/o Mespil Business Centre
Sussex Road, Dublin 4, Ireland (IE)
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Annual Fee
Annual Fee(s) Due Date:
Annual Fee Number:
Last Annual Payment Date:
26/04/2022
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
1400 Euro
Payer:
Computer Packages Inc. (CPI)
Filing date
Document type
Document Description
Number of pages
File Type
19/05/2017
Outgoing Correspondence
Letter no formal defects
1
PDF
/7/8/8/3/3/0800133887/docs/ep10183992.6_2_137638l271.pdf
16/05/2017
Claims
First filed claims
2
PDF
/7/8/8/3/3/0800133887/docs/ep10183992.6_0_claims20170516160905281.pdf
16/05/2017
Incoming Correspondence Electronic
Accompanying letter incoming document
2
PDF
/7/8/8/3/3/0800133887/docs/ep10183992.6_1_incomingcorrespondenceelectronic20170516160906677.pdf